⚠ Official Notice: www.ijisrt.com is the official website of the International Journal of Innovative Science and Research Technology (IJISRT) Journal for research paper submission and publication. Please beware of fake or duplicate websites using the IJISRT name.



Antibiotic Resistance for Urinary Tract Bacteria Among HIV Positive Pregnant Women at Jaramogi Oginga Odinga Teaching and Referral Hospital, Kenya


Authors : Kambale Kisuba; Bernard Guyah; Silas O. Awuor; Collins Ouma

Volume/Issue : Volume 11 - 2026, Issue 2 - February


Google Scholar : https://tinyurl.com/3dje925t

Scribd : https://tinyurl.com/yjzrvnb7

DOI : https://doi.org/10.38124/ijisrt/26feb1096

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.


Abstract : Background Urinary tract infections (UTIs) in pregnant women can lead to serious maternal and fetal complications, especially among those living with HIV, who are more prone to opportunistic infections. Antimicrobial resistance (AMR) can exacerbate these infections and may vary by pregnancy trimester, HIV clinical stage, and UTI type (symptomatic vs. asymptomatic bacteriuria). This study aimed to assess antibiotic resistance in urinary tract bacteria isolated from HIVpositive pregnant women in relationship to pregnancy trimester, UTI type, and HIV clinical stage.  Methods A hospital-based prospective cross-sectional study was conducted at Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH). A total of 168 midstream urine samples were collected from HIV-positive pregnant women attending antenatal clinic and taken to the laboratory for processing. SPSS 25.0 was used for data analysis.  Results UTI prevalence was 23.8%(40/168). Majority 62.5%(105/168) were in HIV stage I. Additionally, 47.6%(80/168) were in second trimester. UTI symptoms were showed in 32.1%(54/168) participants. Self-medication was reported in 28.6%(48/168) of participants. E. coli was the most common Gram-negative isolate 25%(10/40), followed by P. aeruginosa 22.5%(9/40), K. pneumoniae 20%(8/40), and P. mirabilis 12.5%(5/40). Among Gram-positive bacteria: S. aureus was 100% (10/10) sensitive to Clindamycin; Coagulase-negative Staphylococci (CoNS) (5/5)100% sensitive to Nitrofurantoin; and S. saprophyticus showed 100%(2/2) sensitivity to Penicillin, Nitrofurantoin, Clindamycin, and TrimethoprimSulfamethoxazole. Multidrug Resistance (MDR) was observed in 80%(8/30) of E. coli, 77.8%(7/30) of P. aeruginosa, and 62.5%(5/30) of K. pneumoniae. Significant association was found between antibiotic resistance and age of pregnancy, HIV stage and types of UTIs (p<0.05). Conclusion High antibiotic resistance among UTI pathogens complicates empirical treatment. Surveillance of AMR is essential to guide effective therapy, especially in resource-limited settings.

Keywords : Antibiotic Resistance, UTI, HIV, Pregnant Women

References :

  1. Aseel, M., Meer, F.A., Kuwari, M.A. and Ismail, M. Prevalence and Predictors of Asymptomatic Bacteriuria among Pregnant Women Attending Primary Health Care in Qatar. Qatar National Research Strategy, 2011, 1715. https://www.scirp.org/reference/referencespapers?referenceid=2234971, accessed on 4th December 2023.
  2. CDC. Suffering from a urinary tract infection? Centers for Disease Control and Prevention. 2022.  https://www.cdc.gov/antibiotic-use/uti.html, accessed on 4th December 2023.
  3. Schnarr, J. and Smaill, F. Asymptomatic Bacteriuria and Symptomatic Urinary Tract Infections in Pregnancy. European Journal of Clinical Investigation; 2008. 38, 50-57.
  4. Masinde, A., Gumodoka, B., Kilonzo, A. and Mshana, S.E. Prevalence of urinary Tract Infection among Pregnant Women at Bugando Medical Centre, Mwanza, Tanzania. Tanzania Journal of Health Research, 2009. 11, 154-159. https://doi.org/10.4314/thrb.v11i3.47704
  5. Delzell John E., J., & Lefevre, M. L. Urinary Tract Infections During Pregnancy. American Family Physician, 2000. 61(3), 713–721
  6. Gilbert, N.M., O’brien, V.P., Hultgren, S., Macones, G., Lewis, W.G. and Lewis, A.L. Urinary Tract Infection as a Preventable Cause of Pregnancy Complications: Opportunities, Challenges, and a Global Call to Action. Global Advances in Health and Medicine, 2013. 2, 59-69. https://doi.org/10.7453/gahmj.2013.061
  7. Foxman, B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. The American Journal of Medicine, 2002.  113(1, Supplement 1), 5–13. https://doi.org/10.1016/S0002-9343(02)01054-9
  8. Tessema, N. N., Ali, M. M., & Zenebe, M. H. Bacterial associated urinary tract infection, risk factors, and drug susceptibility profile among adult people living with HIV at Haswassa University Comprehensive Specialized Hospital, Hawassa, Southern Esthiopia. Scientific Reports, 2020.  10(1):1-9. https://doi.org/10.1038/s41598-020-67840-7  
  9. Dielubanza, E. J., & Schaeffer, A. J. Urinary tract infections in women. The Medical Clinics of North America, 2011. 95(1), 27–41. https://doi.org/10.1016/j.mcna.2010.08.023
  10. WHO. Ten health issues WHO will tackle this year. 2019. https://www.who.int/news- room/spotlight/ten-threats-to-global-health-in-2019, accessed on 4th December 2023.  
  11. Reygaert, W. C.  An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiology, 2018. 4(3), 482–501. https://doi.org/10.3934/microbiol.2018.3.482
  12. Bigwan E, Wakjissa F. Prevalence of urinary tract infections among HIV patients attending a non-governmental health facility in Jos, Plateau State, Nigeria. International Journal of Biomedical and Advance Research.; 2013. 4(8):528–33.
  13. Kenyan Ministry of Health. Kenya develops national policy to combat antimicrobial resistance – Ministry of Health. 2017. https://www.health.go.ke/kenya-develops- national- policy-to-combat-antimicrobial-resistance, accessed on 4th December 2023.
  14. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology E-book: Elsevier Health Sciences, 2020.
  15. Pezzlo M. Laboratory diagnosis of urinary tract infections: guidelines, challenges, and innovations. Clinical Microbiology Newsletter; 2014. 36(12):87–93.
  16. Bullock NO, Aslanzadeh J. Biochemical profile-based microbial identification systems. Advanced techniques in diagnostic microbiology: Springer; 2013. p. 87–121.
  17. Iskandr K, Molinier  L, Hallit  S  et al.  Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture. Antimicrob Resist Infect Control; 2021; 10: 63–82. https://doi.org/10.1186/s13756-021-00931-w 
  18. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI supplement, Pennsylvania, 19087, USA; 2024. M100, ISBN 978-1-68440-033-1
  19. 19. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing; twenty first       information supplement. 2020. https://clsi.org/media/3481/m100ed30_sample.pdf, accessed on 16th January 2024.
  20. Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection? Journal of the American Medical Association, 2002. 287(20): 2701-2710. PMID:  12020306: https://doi.org/10.1001/jama.287.20.2701
  21. Amaya-Tapia G, Ibarra-Nieto G, Campollo Rivas O, Luis González Sánchez J. Urinary Tract Infection in HIV/AIDS Patients. Urinary Tract Infections - New Insights. Intech Open; Available from. 2023: http://dx.doi.org/10.5772/intechopen.110017
  22. Akinbami A, Bode-Shojobi I, Ajibola S, Oshinaike O, Adediran A, Ojelabi O, et al. Prevalence of asymptomatic bacteriuria in HIV infected patients in a tertiary Hospital in Lagos, Nigeria. World Journal of AIDS. 2013. 3(2):105-110. https://doi.org/10.4236/wja.2013.32014  
  23. Nwadioha S, Nwokedi E, Ikeh I, Egesie J, Kashibu E. Antibiotic susceptibility pattern of uropathogenic bacterial isolates from AIDS patients in a Nigerian tertiary hospital. J Med Med Sci; 2010.  1(11):530–40.
  24. Teklu DS, Negeri AA, Legese MH, Bedada TL, Woldemariam HK, Tullu KD. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrobial Resistance & Infection Control. 2019;8(1):1–12. pmid:30815254
  25. Ngowi BN, Sunguya B, Herman A, Chacha A, Maro E, Rugarabamu LF, Bartlett J, Balandya E, Mteta KA, Mmbaga BT. Prevalence of Multidrug Resistant UTI Among People Living with HIV in Northern Tanzania; 2021. Vol. 21:14 Pages 1623—1633, DOI https://doi.org/10.2147/IDR.S299776 accessed on 14th March 2025.
  26. Marami D, Balakrishnan S, Seyoum B. Prevalence, Antimicrobial Susceptibility Pattern of Bacterial Isolates, and Associated Factors of Urinary Tract Infections among HIV-Positive Patients at Hiwot Fana Specialized University Hospital, Eastern Ethiopia. Canadian Journal of Infectious Diseases and Medical Microbiology. 2019; 2019.  https://doi.org/10.1155/2019/6780354 
  27. Moses Mukosha, Lukundo Nambela, Chiluba Mwila, Micheal Chigunta, Aubrey Chichonyi Kalungia, Mwansa Ketty Lubeya, Bellington Vwalika. Urinary tract infections and associated factors in HIV infected pregnant women at a tertiary hospital in Lusaka, Zambia, Pan African Medical Journal. 2020; 37:328. https://doi.org/10.11604/pamj:2020.328.20245  
  28. Srija Voruganti, Saif Ali Khan, Prevalence and Risk Factors of Urinary Tract Infection in Pregnant Women: Systematic Review and Meta-Analysis; 2023. vol. 5, I. 6, 2582-2160; 1-14. https://doi.org/10.36948/ijfmr.2023.v05i06.9117, accessed on 10th March 2025.

Background Urinary tract infections (UTIs) in pregnant women can lead to serious maternal and fetal complications, especially among those living with HIV, who are more prone to opportunistic infections. Antimicrobial resistance (AMR) can exacerbate these infections and may vary by pregnancy trimester, HIV clinical stage, and UTI type (symptomatic vs. asymptomatic bacteriuria). This study aimed to assess antibiotic resistance in urinary tract bacteria isolated from HIVpositive pregnant women in relationship to pregnancy trimester, UTI type, and HIV clinical stage.  Methods A hospital-based prospective cross-sectional study was conducted at Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH). A total of 168 midstream urine samples were collected from HIV-positive pregnant women attending antenatal clinic and taken to the laboratory for processing. SPSS 25.0 was used for data analysis.  Results UTI prevalence was 23.8%(40/168). Majority 62.5%(105/168) were in HIV stage I. Additionally, 47.6%(80/168) were in second trimester. UTI symptoms were showed in 32.1%(54/168) participants. Self-medication was reported in 28.6%(48/168) of participants. E. coli was the most common Gram-negative isolate 25%(10/40), followed by P. aeruginosa 22.5%(9/40), K. pneumoniae 20%(8/40), and P. mirabilis 12.5%(5/40). Among Gram-positive bacteria: S. aureus was 100% (10/10) sensitive to Clindamycin; Coagulase-negative Staphylococci (CoNS) (5/5)100% sensitive to Nitrofurantoin; and S. saprophyticus showed 100%(2/2) sensitivity to Penicillin, Nitrofurantoin, Clindamycin, and TrimethoprimSulfamethoxazole. Multidrug Resistance (MDR) was observed in 80%(8/30) of E. coli, 77.8%(7/30) of P. aeruginosa, and 62.5%(5/30) of K. pneumoniae. Significant association was found between antibiotic resistance and age of pregnancy, HIV stage and types of UTIs (p<0.05). Conclusion High antibiotic resistance among UTI pathogens complicates empirical treatment. Surveillance of AMR is essential to guide effective therapy, especially in resource-limited settings.

Keywords : Antibiotic Resistance, UTI, HIV, Pregnant Women

Paper Submission Last Date
31 - March - 2026

SUBMIT YOUR PAPER CALL FOR PAPERS
Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe